- $2.07m
- -$0.51m
- $7.00m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.063 | 0.142 | 0.131 | 4.46 | 7 |
Cost of Revenue | |||||
Gross Profit | 0.042 | 0.14 | 0.131 | 0.634 | 2.73 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.05 | 6.29 | 10.7 | 12.6 | 13.7 |
Operating Profit | -5.99 | -6.15 | -10.6 | -8.11 | -6.74 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.5 | -6.16 | -10.5 | -8.35 | -6.71 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.5 | -6.16 | -10.5 | -8.31 | -6.38 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.5 | -6.16 | -10.5 | -8.31 | -6.38 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.5 | -6.16 | -10.5 | -8.31 | -6.38 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -550 | -222 | -200 | -59.4 | -18.6 |
Dividends per Share |